share_log

Shares soared 25%, AnPac Bio-Medical on first disease treatment US patent

Benzinga Real-time News ·  Jun 18, 2021 10:27

$AnPac Bio-Medical Science(ANPC.US)$ has received its first disease treatment patent by the United States Patent and Trademark Office.

logo

  • The patent covers novel medical devices for both disease detection and treatment applications and has 25 claims.

  • The patent covers novel device structures and methods to modify biological samples for treatment purposes. This latest patent is the 21st patent granted to AnPac Bio in the U.S.

  • The Company also announced that its newly launched cancer treatment joint venture has secured, via signed legal documents, over $4 million of capital contributions from multiple funding sources.

  • The funding will be used to fabricate cancer treatment medical devices and the device's subsequent laboratory tests this year.

  • Price Action: ANPC shares are up 25% at $5.42 during the premarket trading session on the last check Friday.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment